Newsroom

Press Release

NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

NeoGenomics Completes Acquisition of Genoptix, Inc.

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients